According to Clovis Oncology's latest financial reports the company's total assets are S$0.44 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2021-12-31 | S$0.63 B | -20.21% |
2020-12-31 | S$0.80 B | -11.26% |
2019-12-31 | S$0.90 B | -23.48% |
2018-12-31 | S$1.17 B | 19.97% |
2017-12-31 | S$0.98 B | 86.38% |
2016-12-31 | S$0.52 B | -47.71% |
2015-12-31 | S$1.00 B | -2.86% |
2014-12-31 | S$1.03 B | 26.22% |
2013-12-31 | S$0.82 B | 361.01% |
2012-12-31 | S$0.17 B | -3.89% |
2011-12-31 | S$0.18 B | 450.45% |
2010-12-31 | S$33.74 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() BioMarin Pharmaceutical BMRN | S$9.10 B | 1,960.99% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | S$135.36 B | 30,540.33% | ๐ฌ๐ง UK |
![]() Pfizer PFE | S$265.02 B | 59,889.33% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | S$246.73 B | 55,749.18% | ๐บ๐ธ USA |
![]() AbbVie ABBV | S$173.47 B | 39,166.09% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | S$113.88 B | 25,677.18% | ๐บ๐ธ USA |